<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-04-27" modified="2018-01-31" version="178">
<accession>Q9H2X6</accession>
<accession>Q75MR7</accession>
<accession>Q8WWI4</accession>
<accession>Q9H2Y1</accession>
<name>HIPK2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Homeodomain-interacting protein kinase 2</fullName>
<shortName>hHIPk2</shortName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">HIPK2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="Biochim. Biophys. Acta" volume="1518" first="168" last="172">
<title>Isolation and characterization of cDNAs for the protein kinase HIPK2.</title>
<authorList>
<person name="Wang Y."/>
<person name="Hofmann T.G."/>
<person name="Runkel L."/>
<person name="Haaf T."/>
<person name="Schaller H."/>
<person name="Debatin K.-M."/>
<person name="Hug H."/>
</authorList>
<dbReference type="PubMed" id="11267674"/>
<dbReference type="DOI" id="10.1016/S0167-4781(00)00308-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF LYS-228</scope>
<source>
<tissue>Liver</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2000-12" db="EMBL/GenBank/DDBJ databases">
<title>Sequencing of hHIPk2, a human homolog of mouse homeodomain interacting protein kinase 2.</title>
<authorList>
<person name="Stukart G.C."/>
<person name="Dias-Neto E."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Frontal cortex</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2003" name="Nature" volume="424" first="157" last="164">
<title>The DNA sequence of human chromosome 7.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Graves T.A."/>
<person name="Pepin K.H."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Maas J."/>
<person name="Jaeger S."/>
<person name="Walker R."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="O'Laughlin M.D."/>
<person name="Schaller M.E."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Cordes M."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Edwards J."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Andrews S."/>
<person name="Isak A."/>
<person name="Vanbrunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Lamar B."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Bielicki L."/>
<person name="Scott K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Harris A."/>
<person name="Strong C.M."/>
<person name="Hou S."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Leonard S."/>
<person name="Rohlfing T."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Abbott A."/>
<person name="Minx P."/>
<person name="Maupin R."/>
<person name="Strowmatt C."/>
<person name="Latreille P."/>
<person name="Miller N."/>
<person name="Johnson D."/>
<person name="Murray J."/>
<person name="Woessner J.P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Schultz B.R."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Nelson J.O."/>
<person name="Berkowicz N."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Bedell J.A."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Chissoe S.L."/>
<person name="Marra M.A."/>
<person name="Raymond C."/>
<person name="Haugen E."/>
<person name="Gillett W."/>
<person name="Zhou Y."/>
<person name="James R."/>
<person name="Phelps K."/>
<person name="Iadanoto S."/>
<person name="Bubb K."/>
<person name="Simms E."/>
<person name="Levy R."/>
<person name="Clendenning J."/>
<person name="Kaul R."/>
<person name="Kent W.J."/>
<person name="Furey T.S."/>
<person name="Baertsch R.A."/>
<person name="Brent M.R."/>
<person name="Keibler E."/>
<person name="Flicek P."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Bailey J.A."/>
<person name="Portnoy M.E."/>
<person name="Torrents D."/>
<person name="Chinwalla A.T."/>
<person name="Gish W.R."/>
<person name="Eddy S.R."/>
<person name="McPherson J.D."/>
<person name="Olson M.V."/>
<person name="Eichler E.E."/>
<person name="Green E.D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="12853948"/>
<dbReference type="DOI" id="10.1038/nature01782"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="1999-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Pierantoni G.M."/>
<person name="Benvenuto G."/>
<person name="Chiariotti L."/>
<person name="Fusco A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 8-1198 (ISOFORM 2)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2000" name="Biochem. Biophys. Res. Commun." volume="277" first="513" last="517">
<title>The serine/threonine kinase HIPK2 interacts with TRADD, but not with CD95 or TNF-R1 in 293T cells.</title>
<authorList>
<person name="Li X."/>
<person name="Wang Y."/>
<person name="Debatin K.-M."/>
<person name="Hug H."/>
</authorList>
<dbReference type="PubMed" id="11032752"/>
<dbReference type="DOI" id="10.1006/bbrc.2000.3700"/>
</citation>
<scope>INTERACTION WITH TRADD</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="290" first="942" last="947">
<title>The homeodomain-interacting protein kinase 2 gene is expressed late in embryogenesis and preferentially in retina, muscle, and neural tissues.</title>
<authorList>
<person name="Pierantoni G.M."/>
<person name="Bulfone A."/>
<person name="Pentimalli F."/>
<person name="Fedele M."/>
<person name="Iuliano R."/>
<person name="Santoro M."/>
<person name="Chiariotti L."/>
<person name="Ballabio A."/>
<person name="Fusco A."/>
</authorList>
<dbReference type="PubMed" id="11798164"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.6310"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="297" first="148" last="153">
<title>HIPK2 associates with RanBPM.</title>
<authorList>
<person name="Wang Y."/>
<person name="Marion Schneider E."/>
<person name="Li X."/>
<person name="Duttenhoefer I."/>
<person name="Debatin K.-M."/>
<person name="Hug H."/>
</authorList>
<dbReference type="PubMed" id="12220523"/>
<dbReference type="DOI" id="10.1016/S0006-291X(02)02020-X"/>
</citation>
<scope>INTERACTION WITH RANBP9</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-228</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="32020" last="32028">
<title>Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.</title>
<authorList>
<person name="Kim E.-J."/>
<person name="Park J.-S."/>
<person name="Um S.-J."/>
</authorList>
<dbReference type="PubMed" id="11925430"/>
<dbReference type="DOI" id="10.1074/jbc.M200153200"/>
</citation>
<scope>INTERACTION WITH TP73; TP53 AND TP63</scope>
<scope>MUTAGENESIS OF LYS-228</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="Nat. Cell Biol." volume="4" first="1" last="10">
<title>Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.</title>
<authorList>
<person name="Hofmann T.G."/>
<person name="Moeller A."/>
<person name="Sirma H."/>
<person name="Zentgraf H."/>
<person name="Taya Y."/>
<person name="Droege W."/>
<person name="Will H."/>
<person name="Schmitz M.L."/>
</authorList>
<dbReference type="PubMed" id="11740489"/>
<dbReference type="DOI" id="10.1038/ncb715"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>INTERACTION WITH TP53 AND CREBBP</scope>
<scope>MUTAGENESIS OF LYS-228</scope>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="4310" last="4314">
<title>PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains.</title>
<authorList>
<person name="Moeller A."/>
<person name="Sirma H."/>
<person name="Hofmann T.G."/>
<person name="Rueffer S."/>
<person name="Klimczak E."/>
<person name="Droege W."/>
<person name="Will H."/>
<person name="Schmitz M.L."/>
</authorList>
<dbReference type="PubMed" id="12907596"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-228</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="8271" last="8277">
<title>HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells.</title>
<authorList>
<person name="Hofmann T.G."/>
<person name="Stollberg N."/>
<person name="Schmitz M.L."/>
<person name="Will H."/>
</authorList>
<dbReference type="PubMed" id="14678985"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DAXX</scope>
<scope>MUTAGENESIS OF LYS-228</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="37722" last="37729">
<title>TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity.</title>
<authorList>
<person name="Tomasini R."/>
<person name="Samir A.A."/>
<person name="Carrier A."/>
<person name="Isnardon D."/>
<person name="Cecchinelli B."/>
<person name="Soddu S."/>
<person name="Malissen B."/>
<person name="Dagorn J.-C."/>
<person name="Iovanna J.L."/>
<person name="Dusetti N.J."/>
</authorList>
<dbReference type="PubMed" id="12851404"/>
<dbReference type="DOI" id="10.1074/jbc.M301979200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH P53DINP1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="38998" last="39005">
<title>Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.</title>
<authorList>
<person name="Harada J."/>
<person name="Kokura K."/>
<person name="Kanei-Ishii C."/>
<person name="Nomura T."/>
<person name="Khan M.M."/>
<person name="Kim Y."/>
<person name="Ishii S."/>
</authorList>
<dbReference type="PubMed" id="12874272"/>
<dbReference type="DOI" id="10.1074/jbc.M307112200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SKI; SMAD1; SMAD2 AND SMAD3</scope>
<scope>MUTAGENESIS OF LYS-228 AND 359-SER--TYR-361</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="8731" last="8737">
<title>Sp100 is important for the stimulatory effect of homeodomain-interacting protein kinase-2 on p53-dependent gene expression.</title>
<authorList>
<person name="Moeller A."/>
<person name="Sirma H."/>
<person name="Hofmann T.G."/>
<person name="Staege H."/>
<person name="Gresko E."/>
<person name="Luedi K.S."/>
<person name="Klimczak E."/>
<person name="Droege W."/>
<person name="Will H."/>
<person name="Schmitz M.L."/>
</authorList>
<dbReference type="PubMed" id="14647468"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207079"/>
</citation>
<scope>INTERACTION WITH SP100</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="FEBS Lett." volume="579" first="6272" last="6278">
<title>Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1.</title>
<authorList>
<person name="Kim Y.H."/>
<person name="Sung K.S."/>
<person name="Lee S.-J."/>
<person name="Kim Y.-O."/>
<person name="Choi C.Y."/>
<person name="Kim Y."/>
</authorList>
<dbReference type="PubMed" id="16253240"/>
<dbReference type="DOI" id="10.1016/j.febslet.2005.10.010"/>
</citation>
<scope>DESUMOYLATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="1883" last="1894">
<title>Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2.</title>
<authorList>
<person name="Gresko E."/>
<person name="Roscic A."/>
<person name="Ritterhoff S."/>
<person name="Vichalkovski A."/>
<person name="del Sal G."/>
<person name="Schmitz M.L."/>
</authorList>
<dbReference type="PubMed" id="16601678"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601077"/>
</citation>
<scope>CLEAVAGE BY CASP6 AT ASP-923 AND ASP-984</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Mol. Cell" volume="24" first="77" last="89">
<title>Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2.</title>
<authorList>
<person name="Roscic A."/>
<person name="Moeller A."/>
<person name="Calzado M.A."/>
<person name="Renner F."/>
<person name="Wimmer V.C."/>
<person name="Gresko E."/>
<person name="Luedi K.S."/>
<person name="Schmitz M.L."/>
</authorList>
<dbReference type="PubMed" id="17018294"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.08.004"/>
</citation>
<scope>INTERACTION WITH CBX4</scope>
<scope>SUMOYLATION AT LYS-32</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4711" last="4719">
<title>Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity.</title>
<authorList>
<person name="Zhang Q."/>
<person name="Wang Y."/>
</authorList>
<dbReference type="PubMed" id="17960875"/>
<dbReference type="DOI" id="10.1021/pr700571d"/>
</citation>
<scope>FUNCTION AS HMGA1 KINASE</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Blood" volume="112" first="3777" last="3787">
<title>PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.</title>
<authorList>
<person name="Wee H.-J."/>
<person name="Voon D.C.-C."/>
<person name="Bae S.-C."/>
<person name="Ito Y."/>
</authorList>
<dbReference type="PubMed" id="18695000"/>
<dbReference type="DOI" id="10.1182/blood-2008-01-134122"/>
</citation>
<scope>FUNCTION AS RUNX1 AND EP300 KINASE</scope>
<scope>MUTAGENESIS OF LYS-228</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="4682" last="4689">
<title>Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1.</title>
<authorList>
<person name="Choi D.W."/>
<person name="Seo Y.-M."/>
<person name="Kim E.-A."/>
<person name="Sung K.S."/>
<person name="Ahn J.W."/>
<person name="Park S.-J."/>
<person name="Lee S.-R."/>
<person name="Choi C.Y."/>
</authorList>
<dbReference type="PubMed" id="18093972"/>
<dbReference type="DOI" id="10.1074/jbc.M708873200"/>
</citation>
<scope>INTERACTION WITH WSB1</scope>
<scope>UBIQUITINATION BY WSB1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="7126" last="7138">
<title>PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.</title>
<authorList>
<person name="Shima Y."/>
<person name="Shima T."/>
<person name="Chiba T."/>
<person name="Irimura T."/>
<person name="Pandolfi P.P."/>
<person name="Kitabayashi I."/>
</authorList>
<dbReference type="PubMed" id="18809579"/>
<dbReference type="DOI" id="10.1128/MCB.00897-08"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION BY FBXO3</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Nat. Cell Biol." volume="10" first="812" last="824">
<title>Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.</title>
<authorList>
<person name="Winter M."/>
<person name="Sombroek D."/>
<person name="Dauth I."/>
<person name="Moehlenbrink J."/>
<person name="Scheuermann K."/>
<person name="Crone J."/>
<person name="Hofmann T.G."/>
</authorList>
<dbReference type="PubMed" id="18536714"/>
<dbReference type="DOI" id="10.1038/ncb1743"/>
</citation>
<scope>INDUCTION BY DNA DAMAGE</scope>
<scope>INTERACTION WITH SIAH1</scope>
<scope>UBIQUITINATION BY SIAH1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Biochim. Biophys. Acta" volume="1793" first="368" last="377">
<title>Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth.</title>
<authorList>
<person name="Nardinocchi L."/>
<person name="Puca R."/>
<person name="Guidolin D."/>
<person name="Belloni A.S."/>
<person name="Bossi G."/>
<person name="Michiels C."/>
<person name="Sacchi A."/>
<person name="Onisto M."/>
<person name="D'Orazi G."/>
</authorList>
<dbReference type="PubMed" id="19046997"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2008.10.013"/>
</citation>
<scope>FUNCTION AS HIF1A TRANSCRIPTION REGULATOR AND ANGIOGENESIS PROMOTER</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Oncogene" volume="28" first="698" last="708">
<title>PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage.</title>
<authorList>
<person name="Gresko E."/>
<person name="Ritterhoff S."/>
<person name="Sevilla-Perez J."/>
<person name="Roscic A."/>
<person name="Froebius K."/>
<person name="Kotevic I."/>
<person name="Vichalkovski A."/>
<person name="Hess D."/>
<person name="Hemmings B.A."/>
<person name="Schmitz M.L."/>
</authorList>
<dbReference type="PubMed" id="19015637"/>
<dbReference type="DOI" id="10.1038/onc.2008.420"/>
</citation>
<scope>FUNCTION AS PML KINASE</scope>
<scope>INTERACTION WITH PML</scope>
<scope>MUTAGENESIS OF LYS-228</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Oncogene" volume="28" first="2535" last="2544">
<title>The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4.</title>
<authorList>
<person name="Yamada D."/>
<person name="Perez-Torrado R."/>
<person name="Filion G."/>
<person name="Caly M."/>
<person name="Jammart B."/>
<person name="Devignot V."/>
<person name="Sasai N."/>
<person name="Ravassard P."/>
<person name="Mallet J."/>
<person name="Sastre-Garau X."/>
<person name="Schmitz M.L."/>
<person name="Defossez P.A."/>
</authorList>
<dbReference type="PubMed" id="19448668"/>
<dbReference type="DOI" id="10.1038/onc.2009.109"/>
</citation>
<scope>FUNCTION AS ZBTB4 KINASE</scope>
<scope>INTERACTION WITH ZBTB4</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E6819" last="E6819">
<title>Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha.</title>
<authorList>
<person name="Nardinocchi L."/>
<person name="Puca R."/>
<person name="Sacchi A."/>
<person name="Rechavi G."/>
<person name="Givol D."/>
<person name="D'Orazi G."/>
</authorList>
<dbReference type="PubMed" id="19714248"/>
<dbReference type="DOI" id="10.1371/journal.pone.0006819"/>
</citation>
<scope>INDUCTION BY ZINC DURING HYPOXIA</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="399" first="155" last="161">
<title>Pancreatic and duodenal homeobox 1 (PDX1) phosphorylation at serine-269 is HIPK2-dependent and affects PDX1 subnuclear localization.</title>
<authorList>
<person name="An R."/>
<person name="da Silva Xavier G."/>
<person name="Semplici F."/>
<person name="Vakhshouri S."/>
<person name="Hao H.X."/>
<person name="Rutter J."/>
<person name="Pagano M.A."/>
<person name="Meggio F."/>
<person name="Pinna L.A."/>
<person name="Rutter G.A."/>
</authorList>
<dbReference type="PubMed" id="20637728"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.07.035"/>
</citation>
<scope>FUNCTION AS PDX1 KINASE</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="394" first="966" last="971">
<title>Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation.</title>
<authorList>
<person name="Kim E.-A."/>
<person name="Kim J.E."/>
<person name="Sung K.S."/>
<person name="Choi D.W."/>
<person name="Lee B.J."/>
<person name="Choi C.Y."/>
</authorList>
<dbReference type="PubMed" id="20307497"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.03.099"/>
</citation>
<scope>FUNCTION AS CTNNB1 KINASE</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="3863" last="3871">
<title>Transcriptional regulation of ferritin and antioxidant genes by HIPK2 under genotoxic stress.</title>
<authorList>
<person name="Hailemariam K."/>
<person name="Iwasaki K."/>
<person name="Huang B.W."/>
<person name="Sakamoto K."/>
<person name="Tsuji Y."/>
</authorList>
<dbReference type="PubMed" id="20980392"/>
<dbReference type="DOI" id="10.1242/jcs.073627"/>
</citation>
<scope>FUNCTION AS ATF1 KINASE</scope>
<scope>INTERACTION WITH ATF1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="Mol. Biol. Cell" volume="21" first="2966" last="2974">
<title>Regulation of genotoxic stress response by homeodomain-interacting protein kinase 2 through phosphorylation of cyclic AMP response element-binding protein at serine 271.</title>
<authorList>
<person name="Sakamoto K."/>
<person name="Huang B.-W."/>
<person name="Iwasaki K."/>
<person name="Hailemariam K."/>
<person name="Ninomiya-Tsuji J."/>
<person name="Tsuji Y."/>
</authorList>
<dbReference type="PubMed" id="20573984"/>
<dbReference type="DOI" id="10.1091/mbc.E10-01-0015"/>
</citation>
<scope>FUNCTION AS CREB1 KINASE</scope>
<scope>INTERACTION WITH CREB1</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="Biochim. Biophys. Acta" volume="1813" first="283" last="297">
<title>Control of nuclear HIPK2 localization and function by a SUMO interaction motif.</title>
<authorList>
<person name="de la Vega L."/>
<person name="Froebius K."/>
<person name="Moreno R."/>
<person name="Calzado M.A."/>
<person name="Geng H."/>
<person name="Schmitz M.L."/>
</authorList>
<dbReference type="PubMed" id="21145359"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2010.11.022"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUMOYLATION</scope>
<scope>NUCLEAR LOCALIZATION SIGNALS</scope>
<scope>MUTAGENESIS OF LYS-803; LYS-805; ARG-833; LYS-835; 885-VAL--SER-892 AND 893-ASP--GLU-899</scope>
<scope>INTERACTION WITH CBX4</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="Exp. Cell Res." volume="317" first="1060" last="1070">
<title>Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.</title>
<authorList>
<person name="Sung K.S."/>
<person name="Lee Y.A."/>
<person name="Kim E.T."/>
<person name="Lee S.R."/>
<person name="Ahn J.H."/>
<person name="Choi C.Y."/>
</authorList>
<dbReference type="PubMed" id="21192925"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2010.12.016"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUMOYLATION</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF 885-VAL--ILE-888 AND 892-SER--ASP-895</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Cell Death Differ." volume="16" first="187" last="194">
<title>How cells switch HIPK2 on and off.</title>
<authorList>
<person name="Sombroek D."/>
<person name="Hofmann T.G."/>
</authorList>
<dbReference type="PubMed" id="18974774"/>
<dbReference type="DOI" id="10.1038/cdd.2008.154"/>
</citation>
<scope>REVIEW ON DNA DAMAGE SIGNALING</scope>
<scope>INDUCTION BY GENOTOXIC AGENTS</scope>
<scope>STABILIZATION BY DNA DAMAGE</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="FEBS J." volume="276" first="6074" last="6083">
<title>Apoptosis and autophagy: Regulation of apoptosis by DNA damage signalling - roles of p53, p73 and HIPK2.</title>
<authorList>
<person name="Bitomsky N."/>
<person name="Hofmann T.G."/>
</authorList>
<dbReference type="PubMed" id="19788416"/>
<dbReference type="DOI" id="10.1111/j.1742-4658.2009.07331.x"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2010" name="Cell Cycle" volume="9" first="1270" last="1275">
<title>HIPK2-a therapeutical target to be (re)activated for tumor suppression: role in p53 activation and HIF-1? inhibition.</title>
<authorList>
<person name="Nardinocchi L."/>
<person name="Puca R."/>
<person name="Givol D."/>
<person name="D'Orazi G."/>
</authorList>
<dbReference type="PubMed" id="20234185"/>
<dbReference type="DOI" id="10.4161/cc.9.7.11125"/>
</citation>
<scope>REVIEW AS HYPOXIA AND TP53 REGULATOR</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="Oncogene" volume="29" first="4378" last="4387">
<title>Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.</title>
<authorList>
<person name="Puca R."/>
<person name="Nardinocchi L."/>
<person name="Givol D."/>
<person name="D'Orazi G."/>
</authorList>
<dbReference type="PubMed" id="20514025"/>
<dbReference type="DOI" id="10.1038/onc.2010.183"/>
</citation>
<scope>REVIEW AS TP53 REGULATOR</scope>
<scope>INDUCTION BY GENOTOXIC AGENTS AND HYPOXIA</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="30789" last="30799">
<title>DNA damage-induced heterogeneous nuclear ribonucleoprotein K SUMOylation regulates p53 transcriptional activation.</title>
<authorList>
<person name="Pelisch F."/>
<person name="Pozzi B."/>
<person name="Risso G."/>
<person name="Munoz M.J."/>
<person name="Srebrow A."/>
</authorList>
<dbReference type="PubMed" id="22825850"/>
<dbReference type="DOI" id="10.1074/jbc.M112.390120"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-32; LYS-953 AND LYS-973</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] GLN-792 AND GLN-1027</scope>
</reference>
<comment type="function">
<text evidence="7 9 11 12 15 18 20 23 24 26 27 28 30 32 33 34 36 37">Serine/threonine-protein kinase involved in transcription regulation, p53/TP53-mediated cellular apoptosis and regulation of the cell cycle. Acts as a corepressor of several transcription factors, including SMAD1 and POU4F1/Brn3a and probably NK homeodomain transcription factors. Phosphorylates PDX1, ATF1, PML, p53/TP53, CREB1, CTBP1, CBX4, RUNX1, EP300, CTNNB1, HMGA1 and ZBTB4. Inhibits cell growth and promotes apoptosis through the activation of p53/TP53 both at the transcription level and at the protein level (by phosphorylation and indirect acetylation). The phosphorylation of p53/TP53 may be mediated by a p53/TP53-HIPK2-AXIN1 complex. Involved in the response to hypoxia by acting as a transcriptional co-suppressor of HIF1A. Mediates transcriptional activation of TP73. In response to TGFB, cooperates with DAXX to activate JNK. Negative regulator through phosphorylation and subsequent proteasomal degradation of CTNNB1 and the antiapoptotic factor CTBP1. In the Wnt/beta-catenin signaling pathway acts as an intermediate kinase between MAP3K7/TAK1 and NLK to promote the proteasomal degradation of MYB. Phosphorylates CBX4 upon DNA damage and promotes its E3 SUMO-protein ligase activity. Activates CREB1 and ATF1 transcription factors by phosphorylation in response to genotoxic stress. In response to DNA damage, stabilizes PML by phosphorylation. PML, HIPK2 and FBXO3 may act synergically to activate p53/TP53-dependent transactivation. Promotes angiogenesis, and is involved in erythroid differentiation, especially during fetal liver erythropoiesis. Phosphorylation of RUNX1 and EP300 stimulates EP300 transcription regulation activity. Triggers ZBTB4 protein degradation in response to DNA damage. Modulates HMGA1 DNA-binding affinity. In response to high glucose, triggers phosphorylation-mediated subnuclear localization shifting of PDX1. Involved in the regulation of eye size, lens formation and retinal lamination during late embryogenesis.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="subunit">
<text evidence="5 7 9 10 11 12 14 15 18 21 22 26 28 32 34 35">Interacts with CREB1, SIAH1, WSB1, CBX4, TRADD, p53/TP53, TP73, TP63, CREBBP, DAXX, P53DINP1, SKI, SMAD1, SMAD2 and SMAD3, but not SMAD4. Interacts with ATF1, PML, RUNX1, EP300, NKX1-2, NKX2-5, SPN/CD43, UBE2I, HMGA1, CTBP1, AXIN1, NLK, MYB, POU4F1, POU4F2, POU4F3, UBE2I, UBL1 and ZBTB4. Probably part of a complex consisting of p53/TP53, HIPK2 and AXIN1. Interacts with SP100; positively regulates TP53-dependent transcription.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-348345"/>
<interactant intactId="EBI-359808">
<id>P61962</id>
<label>DCAF7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-348345"/>
<interactant intactId="EBI-447295">
<id>Q09472</id>
<label>EP300</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-348345"/>
<interactant intactId="EBI-1189067">
<id>P51608</id>
<label>MECP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-348345"/>
<interactant intactId="EBI-925904">
<id>Q01196</id>
<label>RUNX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
<location>PML body</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Concentrated in PML/POD/ND10 nuclear bodies. Small amounts are cytoplasmic.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9H2X6-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9H2X6-2</id>
<name>2</name>
<sequence type="described" ref="VSP_004805 VSP_004806 VSP_004807"/>
</isoform>
<isoform>
<id>Q9H2X6-3</id>
<name>3</name>
<sequence type="described" ref="VSP_004804"/>
</isoform>
<text>Experimental confirmation may be lacking for some isoforms.</text>
</comment>
<comment type="tissue specificity">
<text evidence="6 8">Highly expressed in heart, muscle and kidney. Weakly expressed in a ubiquitous way. Down-regulated in several thyroid and breast tumors.</text>
</comment>
<comment type="induction">
<text evidence="7 22 25 29 31">Unstable in unstressed cells but stabilized upon DNA damage. Induced by UV irradiation and other genotoxic agents (adriamycin ADR, cisplatin CDDP, etoposide, IR, roscovitin), thus triggering p53/TP53 apoptotic response. Consistutively negatively regulated by SIAH1 and WSB1 through proteasomal degradation. This negative regulation is impaired upon genotoxic stress. Repressed upon hypoxia (often associated with tumors), through MDM2- (an E3 ubiquitin ligases) mediated proteasomal degradation, thus inactivating p53/TP53 apoptotic response. This hypoxia repression is reversed by zinc. The stabilization mediated by DNA damage requires the damage checkpoint kinases ATM and ATR.</text>
</comment>
<comment type="PTM">
<text evidence="2">Autophosphorylation at Tyr-361 in the activation loop activates the kinase and promotes nuclear localization.</text>
</comment>
<comment type="PTM">
<text evidence="2 16 18 35 36">Sumoylated. When conjugated it is directed to nuclear speckles. Desumoylated by SENP1 (By similarity). Sumoylation on Lys-32 is promoted by the E3 SUMO-protein ligase CBX4.</text>
</comment>
<comment type="PTM">
<text evidence="21 22 24">Ubiquitinated by FBXO3, WSB1 and SIAH1, leading to rapid proteasome-dependent degradation. The degradation mediated by FBXO3, but not ubiquitination, is prevented in the presence of PML. The degradation mediated by WSB1 and SIAH1 is reversibly reduced upon DNA damage.</text>
</comment>
<comment type="PTM">
<text evidence="17">Cleaved at Asp-923 and Asp-984 by CASP6 in a p53/TP53-dependent manner. The cleaved form lacks the autoinhibitory C-terminal domain (AID), resulting in a hyperactive kinase, which potentiates p53/TP53 Ser-46 phosphorylation and subsequent activation of the cell death machinery.</text>
</comment>
<comment type="miscellaneous">
<text evidence="41">Interesting targets for cancer therapy. HIPK2 deregulation would end up in a multifactorial response leading to tumor chemoresistance by affecting p53/TP53 activity on one hand and to angiogenesis and cell proliferation by affecting HIF1A activity on the other hand. May provide important insights in the process of tumor progression, and may also serve as the crucial point in the diagnostic and therapeutical aspects of cancer. Tumor treatment may potential be improved by zinc supplementation in combination with chemotherapy to address hypoxia (PubMed:20514025).</text>
</comment>
<comment type="similarity">
<text evidence="40">Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. HIPK subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/HIPK2ID40824ch7q34.html"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="AF208291">
<property type="protein sequence ID" value="AAG41236.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF326592">
<property type="protein sequence ID" value="AAL37371.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC005531">
<property type="protein sequence ID" value="AAS00368.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC073184">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC006021">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC141932">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF207702">
<property type="protein sequence ID" value="AAG35710.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS75666.1">
<molecule id="Q9H2X6-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS75667.1">
<molecule id="Q9H2X6-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001106710.1">
<molecule id="Q9H2X6-3"/>
<property type="nucleotide sequence ID" value="NM_001113239.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_073577.3">
<molecule id="Q9H2X6-1"/>
<property type="nucleotide sequence ID" value="NM_022740.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.731417"/>
<dbReference type="ProteinModelPortal" id="Q9H2X6"/>
<dbReference type="SMR" id="Q9H2X6"/>
<dbReference type="BioGrid" id="118815">
<property type="interactions" value="63"/>
</dbReference>
<dbReference type="CORUM" id="Q9H2X6"/>
<dbReference type="DIP" id="DIP-31716N"/>
<dbReference type="ELM" id="Q9H2X6"/>
<dbReference type="IntAct" id="Q9H2X6">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="MINT" id="MINT-234689"/>
<dbReference type="STRING" id="9606.ENSP00000385571"/>
<dbReference type="BindingDB" id="Q9H2X6"/>
<dbReference type="ChEMBL" id="CHEMBL4576"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2034"/>
<dbReference type="iPTMnet" id="Q9H2X6"/>
<dbReference type="PhosphoSitePlus" id="Q9H2X6"/>
<dbReference type="BioMuta" id="HIPK2"/>
<dbReference type="DMDM" id="21431782"/>
<dbReference type="MaxQB" id="Q9H2X6"/>
<dbReference type="PaxDb" id="Q9H2X6"/>
<dbReference type="PeptideAtlas" id="Q9H2X6"/>
<dbReference type="PRIDE" id="Q9H2X6"/>
<dbReference type="TopDownProteomics" id="Q9H2X6-2">
<molecule id="Q9H2X6-2"/>
</dbReference>
<dbReference type="DNASU" id="28996"/>
<dbReference type="Ensembl" id="ENST00000406875">
<molecule id="Q9H2X6-1"/>
<property type="protein sequence ID" value="ENSP00000385571"/>
<property type="gene ID" value="ENSG00000064393"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000428878">
<molecule id="Q9H2X6-3"/>
<property type="protein sequence ID" value="ENSP00000413724"/>
<property type="gene ID" value="ENSG00000064393"/>
</dbReference>
<dbReference type="GeneID" id="28996"/>
<dbReference type="KEGG" id="hsa:28996"/>
<dbReference type="UCSC" id="uc003vvd.5">
<molecule id="Q9H2X6-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="28996"/>
<dbReference type="DisGeNET" id="28996"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000064393.15"/>
<dbReference type="GeneCards" id="HIPK2"/>
<dbReference type="HGNC" id="HGNC:14402">
<property type="gene designation" value="HIPK2"/>
</dbReference>
<dbReference type="HPA" id="HPA007611"/>
<dbReference type="MIM" id="606868">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9H2X6"/>
<dbReference type="OpenTargets" id="ENSG00000064393"/>
<dbReference type="PharmGKB" id="PA29291"/>
<dbReference type="eggNOG" id="KOG0667">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XPET">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119032"/>
<dbReference type="HOGENOM" id="HOG000231785"/>
<dbReference type="HOVERGEN" id="HBG051908"/>
<dbReference type="InParanoid" id="Q9H2X6"/>
<dbReference type="KO" id="K08826"/>
<dbReference type="OMA" id="PHLYTYT"/>
<dbReference type="OrthoDB" id="EOG091G0UMX"/>
<dbReference type="PhylomeDB" id="Q9H2X6"/>
<dbReference type="TreeFam" id="TF105417"/>
<dbReference type="BRENDA" id="2.7.11.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2032785">
<property type="pathway name" value="YAP1- and WWTR1 (TAZ)-stimulated gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5578768">
<property type="pathway name" value="Physiological factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939243">
<property type="pathway name" value="RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known"/>
</dbReference>
<dbReference type="SignaLink" id="Q9H2X6"/>
<dbReference type="SIGNOR" id="Q9H2X6"/>
<dbReference type="ChiTaRS" id="HIPK2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="HIPK2"/>
<dbReference type="GenomeRNAi" id="28996"/>
<dbReference type="PMAP-CutDB" id="Q9H2X6"/>
<dbReference type="PRO" id="PR:Q9H2X6"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000064393"/>
<dbReference type="CleanEx" id="HS_HIPK2"/>
<dbReference type="ExpressionAtlas" id="Q9H2X6">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9H2X6">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0090575">
<property type="term" value="C:RNA polymerase II transcription factor complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001102">
<property type="term" value="F:RNA polymerase II activating transcription factor binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001105">
<property type="term" value="F:RNA polymerase II transcription coactivator activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046332">
<property type="term" value="F:SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046790">
<property type="term" value="F:virion binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007628">
<property type="term" value="P:adult walking behavior"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009952">
<property type="term" value="P:anterior/posterior pattern specification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006978">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048596">
<property type="term" value="P:embryonic camera-type eye morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060059">
<property type="term" value="P:embryonic retina morphogenesis in camera-type eye"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030218">
<property type="term" value="P:erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001654">
<property type="term" value="P:eye development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097193">
<property type="term" value="P:intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042771">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061072">
<property type="term" value="P:iris morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060235">
<property type="term" value="P:lens induction in camera-type eye"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019048">
<property type="term" value="P:modulation by virus of host morphology or physiology"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030514">
<property type="term" value="P:negative regulation of BMP signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030182">
<property type="term" value="P:neuron differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030578">
<property type="term" value="P:PML body organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043388">
<property type="term" value="P:positive regulation of DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of DNA binding transcription factor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046330">
<property type="term" value="P:positive regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032092">
<property type="term" value="P:positive regulation of protein binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030511">
<property type="term" value="P:positive regulation of transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051726">
<property type="term" value="P:regulation of cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010842">
<property type="term" value="P:retina layer formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060395">
<property type="term" value="P:SMAD protein signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007224">
<property type="term" value="P:smoothened signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007179">
<property type="term" value="P:transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050882">
<property type="term" value="P:voluntary musculoskeletal movement"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Homeodomain-interacting protein kinase 2" id="PRO_0000085995">
<location>
<begin position="1"/>
<end position="1198"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="4">
<location>
<begin position="199"/>
<end position="527"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="40">
<location>
<begin position="205"/>
<end position="213"/>
</location>
</feature>
<feature type="region of interest" description="Transcriptional corepression" evidence="2">
<location>
<begin position="97"/>
<end position="230"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DAXX" evidence="15">
<location>
<begin position="189"/>
<end position="520"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SKI and SMAD1" evidence="12">
<location>
<begin position="539"/>
<end position="844"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with POU4F1" evidence="2">
<location>
<begin position="752"/>
<end position="897"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CTBP1" evidence="2">
<location>
<begin position="774"/>
<end position="876"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HMGA1" evidence="2">
<location>
<begin position="787"/>
<end position="897"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TP53 and TP73" evidence="9">
<location>
<begin position="846"/>
<end position="941"/>
</location>
</feature>
<feature type="region of interest" description="Required for localization to nuclear speckles" evidence="2">
<location>
<begin position="873"/>
<end position="980"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with UBE2I" evidence="2">
<location>
<begin position="873"/>
<end position="907"/>
</location>
</feature>
<feature type="region of interest" description="SUMO interaction motifs (SIM); required for nuclear localization and kinase activity">
<location>
<begin position="884"/>
<end position="908"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with AXIN1" evidence="2">
<location>
<begin position="935"/>
<end position="1049"/>
</location>
</feature>
<feature type="region of interest" description="Autoinhibitory domain (AID)">
<location>
<begin position="984"/>
<end position="1198"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal 1 (NLS1)">
<location>
<begin position="802"/>
<end position="805"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal 2 (NLS2)">
<location>
<begin position="832"/>
<end position="835"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="1088"/>
<end position="1094"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="40">
<location>
<position position="324"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="40">
<location>
<position position="228"/>
</location>
</feature>
<feature type="site" description="Cleavage; by CASP6">
<location>
<begin position="923"/>
<end position="924"/>
</location>
</feature>
<feature type="site" description="Cleavage; by CASP6">
<location>
<begin position="984"/>
<end position="985"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="16"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="118"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="135"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="141"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="252"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="273"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="3">
<location>
<position position="361"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="441"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="482"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="517"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="566"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="634"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="668"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="687"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="815"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="827"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="934"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="992"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="1041"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="1155"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="1188"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="18">
<location>
<position position="32"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="1">
<location>
<position position="32"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="1">
<location>
<position position="953"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="1">
<location>
<position position="973"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="2">
<location>
<position position="1191"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_004804" evidence="38">
<location>
<begin position="595"/>
<end position="621"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_004805" evidence="39">
<location>
<begin position="808"/>
<end position="907"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_004806" evidence="39">
<original>VNTSHHSSSYKSKSSSNVTSTSGHSSGSSS</original>
<variation>GNLGPGQGRNLSLESGFPAFLLLEMLLYGS</variation>
<location>
<begin position="989"/>
<end position="1018"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_004807" evidence="39">
<location>
<begin position="1019"/>
<end position="1198"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56132157." id="VAR_040547" evidence="19">
<original>R</original>
<variation>Q</variation>
<location>
<position position="792"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35255718." id="VAR_040548" evidence="19">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1027"/>
</location>
</feature>
<feature type="mutagenesis site" description="Locates in the nucleoplasm, no effect on interaction with RANBP9, but loss of kinase activity toward PML, RUNX1 and EP300." evidence="6 7 9 10 12 13 15 23 26">
<original>K</original>
<variation>A</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes enzymatic activity, no effect on interaction with TP53 and TP73 or on BMP-induced transcriptional activation. Enhances BMP-induced transcriptional activation; when associated with 359-AAF-361." evidence="6 7 9 10 12 13 15 23 26">
<original>K</original>
<variation>R</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances BMP-induced transcriptional activation; when associated with R-228." evidence="12">
<original>STY</original>
<variation>AAF</variation>
<location>
<begin position="359"/>
<end position="361"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired nuclear localization; when associated with A-805." evidence="35">
<original>K</original>
<variation>A</variation>
<location>
<position position="803"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired nuclear localization; when associated with A-803." evidence="35">
<original>K</original>
<variation>A</variation>
<location>
<position position="805"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired nuclear localization." evidence="35">
<original>R</original>
<variation>A</variation>
<location>
<position position="833"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired nuclear localization." evidence="35">
<original>K</original>
<variation>E</variation>
<location>
<position position="835"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of SUMO and CBX4 interaction, and impaired nuclear and PML-nuclear bodies localization." evidence="35">
<original>VSVITISS</original>
<variation>KFMHFHRM</variation>
<location>
<begin position="885"/>
<end position="892"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of SUMO interaction, and impaired nuclear and PML-nuclear bodies localization." evidence="36">
<original>VSVI</original>
<variation>KSAK</variation>
<location>
<begin position="885"/>
<end position="888"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of SUMO interaction, and impaired nuclear and PML-nuclear bodies localization." evidence="36">
<original>SDTD</original>
<variation>ADTA</variation>
<location>
<begin position="892"/>
<end position="895"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of SUMO and CBX4 interaction, and impaired nuclear and PML-nuclear bodies localization." evidence="35">
<original>DTDEEEE</original>
<variation>NFNQQQQ</variation>
<location>
<begin position="893"/>
<end position="899"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAG41236." ref="1" evidence="40">
<original>I</original>
<variation>V</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAG41236." ref="1" evidence="40">
<original>L</original>
<variation>P</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAG41236." ref="1" evidence="40">
<original>T</original>
<variation>S</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAG35710." ref="4" evidence="40">
<original>S</original>
<variation>F</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAG35710." ref="4" evidence="40">
<original>V</original>
<variation>S</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAG35710." ref="4" evidence="40">
<original>L</original>
<variation>S</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAG41236." ref="1" evidence="40">
<original>H</original>
<variation>R</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAL37371." ref="2" evidence="40">
<original>N</original>
<variation>I</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAG35710." ref="4" evidence="40">
<original>P</original>
<variation>S</variation>
<location>
<position position="669"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAG35710." ref="4" evidence="40">
<original>T</original>
<variation>N</variation>
<location>
<position position="711"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAG35710." ref="4" evidence="40">
<original>PPA</original>
<variation>SPT</variation>
<location>
<begin position="717"/>
<end position="719"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAG35710." ref="4" evidence="40">
<original>T</original>
<variation>D</variation>
<location>
<position position="724"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QZR5"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11032752"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11267674"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11740489"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11798164"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11925430"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12220523"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12851404"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12874272"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12907596"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14647468"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14678985"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16253240"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16601678"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17018294"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17960875"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18093972"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18536714"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18695000"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18809579"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18974774"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19015637"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19046997"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19448668"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19714248"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20307497"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20514025"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20573984"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20637728"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20980392"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21145359"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21192925"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22825850"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="39" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="40" type="ECO:0000305"/>
<evidence key="41" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20514025"/>
</source>
</evidence>
<sequence length="1198" mass="130966" checksum="6022D5710E8D2D93" modified="2002-06-06" version="2">
MAPVYEGMASHVQVFSPHTLQSSAFCSVKKLKIEPSSNWDMTGYGSHSKVYSQSKNIPLS
QPATTTVSTSLPVPNPSLPYEQTIVFPGSTGHIVVTSASSTSVTGQVLGGPHNLMRRSTV
SLLDTYQKCGLKRKSEEIENTSSVQIIEEHPPMIQNNASGATVATATTSTATSKNSGSNS
EGDYQLVQHEVLCSMTNTYEVLEFLGRGTFGQVVKCWKRGTNEIVAIKILKNHPSYARQG
QIEVSILARLSTESADDYNFVRAYECFQHKNHTCLVFEMLEQNLYDFLKQNKFSPLPLKY
IRPVLQQVATALMKLKSLGLIHADLKPENIMLVDPSRQPYRVKVIDFGSASHVSKAVCST
YLQSRYYRAPEIILGLPFCEAIDMWSLGCVIAELFLGWPLYPGASEYDQIRYISQTQGLP
AEYLLSAGTKTTRFFNRDTDSPYPLWRLKTPDDHEAETGIKSKEARKYIFNCLDDMAQVN
MTTDLEGSDMLVEKADRREFIDLLKKMLTIDADKRITPIETLNHPFVTMTHLLDFPHSTH
VKSCFQNMEICKRRVNMYDTVNQSKTPFITHVAPSTSTNLTMTFNNQLTTVHNQAPSSTS
ATISLANPEVSILNYPSTLYQPSAASMAAVAQRSMPLQTGTAQICARPDPFQQALIVCPP
GFQGLQASPSKHAGYSVRMENAVPIVTQAPGAQPLQIQPGLLAQQAWPSGTQQILLPPAW
QQLTGVATHTSVQHATVIPETMAGTQQLADWRNTHAHGSHYNPIMQQPALLTGHVTLPAA
QPLNVGVAHVMRQQPTSTTSSRKSKQHQSSVRNVSTCEVSSSQAISSPQRSKRVKENTPP
RCAMVHSSPACSTSVTCGWGDVASSTTRERQRQTIVIPDTPSPTVSVITISSDTDEEEEQ
KHAPTSTVSKQRKNVISCVTVHDSPYSDSSSNTSPYSVQQRAGHNNANAFDTKGSLENHC
TGNPRTIIVPPLKTQASEVLVECDSLVPVNTSHHSSSYKSKSSSNVTSTSGHSSGSSSGA
ITYRQQRPGPHFQQQQPLNLSQAQQHITTDRTGSHRRQQAYITPTMAQAPYSFPHNSPSH
GTVHPHLAAAAAAAHLPTQPHLYTYTAPAALGSTGTVAHLVASQGSARHTVQHTAYPASI
VHQVPVSMGPRVLPSPTIHPSQYPAQFAHQTYISASPASTVYTGYPLSPAKVNQYPYI
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>